Thailand in 2023 growing only 1.9%, decelerating from 2.5% in the previous year, from a slowdown in public investment and public consumption due to the delay of government’s budget allocation, although the
decelerating rate from 1.9% in the previous year, due to the delay of government’s budget allocation. Hence, the NESDB has cut down its growth forecast for the Thai economy in 2024 to the range of 2 .0%-3.0%, in
-owned of the Listed Subsidiary 2. The Construction of Wattanapat Samui Hospital Building Contractor: Waiting 3. Buying the Medical Instruments The Company will appropriately make a purchase from
www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th a surge in revenues from sales of
2017 as follows: Profit and Loss Statement Total Revenue The company earned THB 200.5 mn in Q2/2017, decrease from the same period in last year amounting to THB 18.6 mn by 8.5% can be summarized as
period ended on March 31, 2016, as follows: Particulars Q1/2016 Q1/2015 Increase (Decrease) Million Baht Million Baht Million Baht % Revenue Revenue from selling immovable property 222.23 111.55 110.69
marketing activities can be cause of increasing in cost of goods sold but in the long run it will emphasize FN brand awareness and increase FN brand equity. However, to dampening the impact from higher cost
second quarter ended June 30, 2020 which the details are as follows: Unit: million Baht For 3-month period (Apr-Jun) 2020 2019 Change % Increase (Decrease) Revenue from sale of goods 128.52 164.02 (35.50
ended 30 September 2019, which net profit has changed more than 20% from the last year as follows: Statement of Comprehensive Income Unit: Million Baht 30 September 2019 30 September 2018 Increased